What end of Eli Lilly's weight-loss drug shortage means for the competition
- Posted on October 4, 2024
- By AOL
- 3 Views
What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?
